A novel compound of triphenyltin(IV) with N-tert-butoxycarbonyl-l-ornithine causes cancer cell death by inducing a p53-dependent activation of the mitochondrial pathway of apoptosis
Triphenyltin(IV) compound with N-tert-butoxycarbonyl-l-ornithine has been synthesized. Antiproliferative activity was evaluated in vitro on different tumor cell lines. IC50 values are from 20 to 60 times lower than cisplatin. Ph3Sn(Boc-Orn-O) induced apoptosis of HepG2 cells via mitochondria-dependent pathway.